Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its AI-powered Spectral CT Verida system.
April 22, 2026Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer ...
Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its Rembra platform of scanning systems.
Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending ...
Last month, Philips obtained FDA clearance for DeviceGuide, an AI-based software designed to provide physicians with ...
Philips has received Food and Drug Administration clearance for an artificial intelligence-enabled CT system. The 510(k) ...
Royal Philips (PHG) announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration for its new detector-based spectral computed tomography radiotherapy ...
Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Spectral CT 7500 RT ...
Philips has secured an FDA clearance for what it describes as the world’s first imager to combine spectral CT with four-dimensional captures in a single scan, with a design specifically targeting the ...
Philips has introduced Verida, described as the first detector-based spectral CT system fully powered by AI. According to a Nov. 30 news release, Verida integrates AI across the imaging chain, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results